1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) National comorbidity survey replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095–3105

2. Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55:580–592

3. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, VanRompay MI, Eisenberg DM (2001) The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158:289–294

4. Thachil AF, Mohan R, Bhugra D (2007) The evidence base of complementary and alternative therapies in depression. J Affect Disord 97:23–35

5. Muanda FN, Dicko A, Soulimani R (2010) Assessment of polyphenolic compounds, in vitro antioxidant and anti-inflammation properties of Securidaca longepedunculata root barks. C R Biol 333:663–669

6. Zhang Z (2004) Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–1699

7. De la Cruz M (1991) CÓDICE DE LA CRUZ-BADIANO: Libellus de medicinalibus indorum herbis, 1st edn. Fondo de Cultura Economica, México

8. Guadarrama-Cruz G, Alarcón-Aguilar FJ, Lezama-Velasco R, Vázquez-Palacios G, Bonilla-Jaime H (2008) Antidepressant-like effects of Tagetes lucida Cav. in the forced swimming test. J Ethnopharmacol 12:277–281

9. Guadarrama-Cruz G, Alarcón-Aguilar FJ, Vega-Ávila E, Vázquez-Palacios G, Bonilla-Baime H (2012) Antidepressant-like effect of the aqueous extract of Tagetes lucida Cav. in rats: involvement of the serotoninergic system. Am J Chin Med 40(4):753–768

10. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants. Psychopharmacology (Berl.) 121:66–72

11. Vazquez-Palacios G, Bonilla-Jaime H, Velázquez-Moctezuma J (2004) Antidepressant-like effects of the acute and chronic administration of nicotine in the forced swimming test and its interaction with fluoxetine. Pharmacol Biochem Behav 78:165–169

12. Dixon AK (1998) Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. Br J Med Psychol 71(Pt 4):417–445

13. Müller S, Tirapelli CR, de Oliveira AM, Murillo R, Castro V, Merfort I (2003) Studies of ent-kaurane diterpenes from Oyedaea verbesinoides for their inhibitory activity on vascular smooth muscle contraction. Phytochemistry 63(4):391–396

14. Rodrigues AL, da Silva GL, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA, Calixto JB, Santos AR (2002) Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70(12):1347–1358

15. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H (2006) Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. J Hum Genet 78:804–814

16. Christiansen L, Tan Q, Iachina M, Bathum L, Kruse TA, McGue M, Christensen K (2007) Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biol Psych 61:223–230

17. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554

18. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571–625

19. Hensler JG (2002) Differential regulation of 5-HT 1A receptors—G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26:565–573

20. O’Neill MF, Conway MW (2001) Role of 5-HT 1A and 5-HT 1B receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24:391–398

21. Rénéric JP, Bouvard M, Stinus L (2001) Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Neuropsychopharmacology 24:379–390

22. Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ (1993) Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Br J Pharmacol 108:669–677

23. O’Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I (2007) Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl.) 192(3):357–371

24. Eckeli AL, Dach F, Rodrigues AL (2000) Acute treatments with GMP produce antidepressant-like effects in mice. Neuroreport 11(9):1839–1843

25. Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo G (2004) Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 369:547–553

26. Harkin A, Shanahan E, Kelly JP, Connor TJ (2003) Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioral and neurochemical responses to the antidepressant fluoxetine. Eur J Neurosci 18:1021–1027

27. Wieland S, Lucki I (1990) Antidepressant-like activity of 5-HT 1A agonists measured with the forced swim test. Psychopharmacology (Berl.) 101:497–504

28. Chojnacka-Wojcik E, Tatarczynska E, Golembiowska K, Przegalinski E (1991) Involvement of 5-HT 1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. Neuropharmacology 30:711–717

29. Albert PR (2012) Transcriptional regulation of the 5-HT1A receptor: implications for mental illness. Philos Trans R Soc Lond B Biol Sci 367:2402–2415

30. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51(3):248–251

31. Cunha MP, Pazini FL, Oliveira Á, Machado DG, Rodrigues AL (2013) Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. Brain Res Bull 95:61–69. doi:10.1016/j.brainresbull.2013.01.005

32. Cryan JF, Leonard BE (2000) 5-HT 1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum Psychopharmacol 15:113–135

33. Cryan JF, Lucki I (2000) Antidepressant-like behavior effects mediated by 5-hydroxytryptamine (2C) receptors. J Pharmacol Exp Ther 295:1120–1126

34. Boothman LJ, Mitchell SN, Sharp T (2006) Investigation of the SSRI augmentation properties of 5-HT 2 receptor antagonists using in vivo microdialysis. Neuropharmacology 50:726–732

35. Zomkowski ADE, Rosa AO, Lin J, Santos ARS, Calixto JB, Rodrigues ALS (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant-like effect in the mouse forced swimming test. Brain Res 1023:253–263

36. Khisti RT, Chopde CT (2000) Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Res 865:291–300

37. Barauna SC, Kaster MP, Heckert BT, Nascimento KS, Rossi FM, Teixeira EH, Cavada BS, Rodrigues AL, Leal RB (2006) Antidepressant-like effect of lectin from Canavalia brasiliensis (ConBr) administered centrally in mice. Pharmacol Biochem Behav 85:160–169

38. Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435–451

39. Taylor S, Stein MB (2005) The future of selective serotonin reuptake inhibitors (SSRIs) in psychiatric treatment. Med Hypotheses 66:14–21

40. Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18:85–95

41. Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl.) 115:285–288

42. Souza LC, de Gomes MG, Goes AT, Del Fabbro L, Filho CB, Boeira SP (2010) Jesse CR (2013) Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice. Prog Neuropsychopharmacol Biol Psych 10(40):103–109. doi:10.1016/j.pnpbp.2012.09.003

43. Bhutada P, Mundhada Y, Bansod K, Ubgade A, Quazi M, Umathe S, Mundhada D (2010) Reversal by quercetin of corticotrophin releasing factor induced anxiety and depression-like effect in mice. Prog Neuropsychopharmacol Biol Psych 34:955–960

44. Volke V, Wegener G, Bourin M, Vasar E (2003) Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140(1–2):141–147

45. Sevgi S, Ozek M, Eroglu L (2006) L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol 28(2):95–99